Nonhuman primates: Their role in assessing developmental effects of immunomodulatory agents

Human and Experimental Toxicology

Volumn 19, Issue 4, 2000, Pages 219-225

  Hendrickx, A G ^a   Makori, N ^a   Peterson, P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biopharmaceutics; Fetus; Immunotoxicity; Macaque; Reproduction; Thymus

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOMODULATING AGENT; RETINOIC ACID; TRIAMCINOLONE ACETONIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; DRUG DEVELOPMENT; IMMUNE SYSTEM; IMMUNOCOMPETENCE; LYMPHOCYTE; MACACA; MENSTRUAL CYCLE; NEURAL CREST; NONHUMAN; ORGANOGENESIS; PHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE; PRIMATE; PRIORITY JOURNAL; THYMUS; THYMUS APLASIA; TOXICOLOGY; ZINC DEFICIENCY;

ANIMALIA; MACACA; MACACA MULATTA; PRIMATES;

EID: 0033945551     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/096032700678815756     Document Type: Conference Paper

References (45)

1. Henck JW et al. Reproductive toxicity testing of therapeutic biotechnology agents. Teratology 1996; 53: 185-195.
2. Hendrickx AG, Cukierski M. Reproductive and developmental toxicology in nonhuman primates. In: Preclinical Safety of Biotechnology Products Intended for Human Use. Alan R. Liss, Inc: New York, 1987.
3. Hendrickx AG, Dukelow WR. Reproductive biology. In: Nonhuman Primates in Biomedical Research: Biology and Management. Academic Press: New York, 1995.
4. Hearn JP, Hendrickx AG, Webley GE, Peterson PE. Normal and abnormal embryo-fetal development in mammals. In: Marshall's Physiology of Reproduction, Vol. 3. Chapman & Hall: London, 1994.
5. Endors AC. Implantation. In: Encyclopedia of Human Biology, Vol. 4. Chapman and Hall: New York, 1991.
6. Carlson BM. Cleavage and implantation. In: Human Embryology and Developmental Biology. Mosby: Baltimore, 1994.
7. McGhee JR, Mestecky J. In defense of mucosal surfaces: development of novel vaccines: for IgA responses at the portals of entry of microbial pathogens. Infectious Disease Clinics of North America 1990; 4: 315-334.
8. Lu FX et al. Immunoglobulin concentrations and antigen-specific antibody levels in cervicovaginal lavages of rhesus macaques are influenced by the stage of the menstrual cycle. Infection and Immunity 1999; 67: 6321-6328.
9. O'Rahilly R, Müller F. Developmental stages in human embryos including a revision of Streeter's "Horizons" and a survey of the Carnegie Collection. Contributions to Embryology Carnegie Institution 1987; 637: 65-201.
10. Gribnau AA, Geijsberts LG. Developmental stages in the rhesus monkey (Macaca mulatta). Advances in Anatomy, Embryology and Cell Biology 1981; 69: 1-84.
11. Makori N et al. Developmental stages in the cynomolgus monkey (Macaca fascicularis). Primates 1996; 37: 351-361.
12. Lammer EJ et al. Retinoic acid embryopathy. New England Journal of Medicine 1985; 313: 837-841.
13. Hendrickx AG, Tzimas G, Korte R, Hummler H. Retinoid teratogenicity in the macaque: verification of dosing regimen. Journal of Medical Primatology 1998; 27: 310-318.
14. Bockman DE, Kirby ML. Dependence of thymus development on derivatives of neural crest. Science 1984; 223: 498-500.
15. Peterson PE, Blankenship TN, Wilson DB, Hendrickx AG. Analysis of hindbrain neural crest migration in the long-tailed monkey (Macaca fascicularis). Anatomy and Embryology 1996; 194: 235-246.
16. Bockman DE. Development of the thymus. Microscopy Research and Technique 1997; 38: 209-215.
17. Makori N et al. 13-cis-Retinoic acid alters neural crest cells expressing Krox-20 and Pax-2 in macaque embryos. Anatomical Record 1999; 255: 142-154.
18. Tanimura T, Tanioka Y. Comparison of embryonic and fetal development in man and rhesus monkey. In: Breeding Simians for Developmental Biology, Laboratory Animal Handbooks. Laboratory Animals Limited: London, 1975.
19. Lawton AR, Cooper MD. Ontogeny of immunity. In: Immunologic Disorders in Infants and Children. Saunders: Philadelphia, 4th edn., 1996.
20. Adkins B et al. Early events in T-cell maturation. Annual Review of Immunology 1987; 5: 325-365.
21. Gelfand EW, Finkel TH. The t-lymphocyte system. In: Immunologic Disorders in Infants and Children. Saunders: Philadelphia, 4th edn., 1996.
22. Hendrickx AG et al. Teratogenic effects of triamcinolone on the skeletal and lymphoid systems in nonhuman primates. Federation Proceedings 1975; 34: 1661-1665.
23. Hendrickx AG, Hummler H, Oneda S. Vitamin A teratogenicity and risk assessment in the cynomolgus monkey. Teratology 1998; 55: 68.
24. Golub MS et al. Studies of marginal zinc deficiency in rhesus monkeys: I. Influence on pregnant dams. American Journal of Clinical Nutrition 1984; 39: 265-280.
25. Haynes DC et al. Long-term marginal zinc deprivation in rhesus monkeys: I. Effects on adult breeders before conception. American Journal of Clinical Nutrition 1987; 45: 1492-1502.
26. Haynes DC et al. Studies of marginal zinc deprivation in rhesus monkeys: IV. Influence on the immunohematology of infants in the first year. The American Journal of Nutrition 1985; 42: 252-262.
27. Vruwink KG et al. Moderate zinc deficiency in rhesus: an intrinsic defect of neutrophil chemotaxis corrected by zinc repletion. The Journal of Immunology 1991; 146: 244-249.
28. Trown PW, Wills RJ, Kamm JJ. The preclinical development of Roferon R-A. Cancer 1986; 57: 1648-1656.
29. Little BB. Immunosuppressant therapy during gestation. Seminars in Perinatology 1997; 21: 143-148.
30. Ostensen M, Ramsey-Goldman R. Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options? Drug Safety 1998; 19: 389-410.
31. Rayburn WF. Connective tissue disorders and pregnancy: recommendations for prescribing. Journal of Reproductive Medicine 1998; 43: 341-349.
32. Hou S. Pregnancy in chronic renal insufficiency and end-stage renal disease. American Journal of Kidney Diseases 1999; 33: 235-252.
33. Penn I, Makowski EL, Harris P. Parenthood following renal transplantation. Kidney International 1980; 18: 221-233.
34. Davidson JM. Pregnancy in renal allograft recipients: problems, prognosis and practicalities. Balliere's Clinical Obstetrics and Gynecology 1994; 8: 501-525.
35. Haugen G et al. Pregnancy outcome in renal allograft recipients in Norway: the importance of immunosuppressive drug regimen and health status before pregnancy. Acta Obstetrics and Gynecology Scandinavia 1994; 73: 541-546.
36. Takahashi N, Nishida H, Hoshi J. Severe B cell depletion in newborns from renal transplant mothers taking immunosuppressive agents. Transplantation 1994; 57: 1617-1621.
37. Jain A et al. FK506 and pregnancy in liver transplant patients. Transplantation 1993; 56: 751.
38. Laifer SA, Yeagley CJ, Armitage JM. Pregnancy after cardiac transplantation. American Journal of Perinatology 1994; 11: 217-219.
39. Warrell DW, Taylor R. Outcome for the fetus of mothers receiving prednisolone during pregnancy. Lancet 1968; 1: 117-118.
40. Reinisch JM et al. Prenatal exposure to prednixone in humans and animals retards uterine growth. Science 1978; 202: 436-438.
41. Lee F et al. Low-dose corticoid therapy for anovulation: effect upon fetal weight. Obstetrics and Gynecology 1982; 60: 314-317.
42. Dombroski RA. Autoimmune disease in pregnancy. Medical Clinics of North America 1989; 73: 605-621.
43. Dencker L, Lindquist NG, Ullberg S. Distribution of an 125 I-labeled chloroquine analogue in a pregnant macaca monkey. Toxicology 1975; 5: 255-265.
44. Miyamoto T et al. Gold therapy in bronchial asthma-special emphasis upon blood level of gold and its teratogenicity. Journal of Japanese Society of Internal Medicine 1974; 63: 1190-1197.
45. Guo Y et al. Endocrine biomarkers of early fetal loss in cynomolgus monkeys (Macaca fascicularis) following exposure to dioxin. Biology of Reproduction 1999; 60: 707-713.